Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason E Stout

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 7, 2014
Understanding the costs of better tuberculosis diagnosticsJason E Stout
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 29, 2015
The cost of 'free' tuberculosis careJason E Stout
Expert Review of Anti-Infective Therapy|December 22, 2006
Evaluation and management of patients with pulmonary nontuberculous mycobacterial infectionsJason E Stout
North Carolina Medical Journal|October 30, 2013
The race to eliminate tuberculosisJason E Stout
Expert Opinion on Drug Safety|May 25, 2004
Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infectionJason E Stout
JID Innovations : Skin Science From Molecules to Population Health|February 24, 2022
Understanding and Communicating Risk: Assessing Both Relative and Absolute Risk Is Absolutely NecessarySofia Zavala, Jason E Stout
American Journal of Respiratory and Critical Care Medicine|May 8, 2008
Predicting tuberculosis: does the IGRA tell the tale?Jason E Stout, Dick Menzies
American Journal of Respiratory and Critical Care Medicine|August 22, 2024
A Balancing Act: Finding the Right Dose of Pyrazinamide to Treat TuberculosisSofia Zavala, Jason E Stout
American Journal of Respiratory and Critical Care Medicine|March 16, 2017
A Breath of Fresh Air for Patients with Pulmonary Nontuberculous Mycobacterial InfectionJason E Stout, Kristen V Dicks
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2007
Pharmacokinetics of rifampicinL Beth Gadkowski, Jason E Stout
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 7, 2014
Understanding the costs of better tuberculosis diagnosticsJason E Stout
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 29, 2015
The cost of 'free' tuberculosis careJason E Stout
Expert Review of Anti-Infective Therapy|December 22, 2006
Evaluation and management of patients with pulmonary nontuberculous mycobacterial infectionsJason E Stout
North Carolina Medical Journal|October 30, 2013
The race to eliminate tuberculosisJason E Stout
Expert Opinion on Drug Safety|May 25, 2004
Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infectionJason E Stout
JID Innovations : Skin Science From Molecules to Population Health|February 24, 2022
Understanding and Communicating Risk: Assessing Both Relative and Absolute Risk Is Absolutely NecessarySofia Zavala, Jason E Stout
American Journal of Respiratory and Critical Care Medicine|May 8, 2008
Predicting tuberculosis: does the IGRA tell the tale?Jason E Stout, Dick Menzies
American Journal of Respiratory and Critical Care Medicine|August 22, 2024
A Balancing Act: Finding the Right Dose of Pyrazinamide to Treat TuberculosisSofia Zavala, Jason E Stout
American Journal of Respiratory and Critical Care Medicine|March 16, 2017
A Breath of Fresh Air for Patients with Pulmonary Nontuberculous Mycobacterial InfectionJason E Stout, Kristen V Dicks
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2007
Pharmacokinetics of rifampicinL Beth Gadkowski, Jason E Stout
Pageof 14